0001493152-23-038415.txt : 20231026 0001493152-23-038415.hdr.sgml : 20231026 20231026171525 ACCESSION NUMBER: 0001493152-23-038415 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231016 FILED AS OF DATE: 20231026 DATE AS OF CHANGE: 20231026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FR Capital Holdings, L.P. CENTRAL INDEX KEY: 0001776703 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36581 FILM NUMBER: 231351026 BUSINESS ADDRESS: STREET 1: 2400 MARKET STREET STREET 2: SUITE 237 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 610-834-1461 MAIL ADDRESS: STREET 1: 2400 MARKET STREET STREET 2: SUITE 237 CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Notable Labs, Ltd. CENTRAL INDEX KEY: 0001603207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 320 HATCH DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 415-851-2410 MAIL ADDRESS: STREET 1: 320 HATCH DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: Vascular Biogenics Ltd. DATE OF NAME CHANGE: 20140320 3 1 ownership.xml X0206 3 2023-10-16 0 0001603207 Notable Labs, Ltd. NTBL 0001776703 FR Capital Holdings, L.P. 2400 MARKET STREET, SUITE 237 PHILADELPHIA PA 19103 0 0 1 0 Ordinary Shares, par value NIS 0.35 each 1037345 I See Footnote FR Capital Holdings, L.P. (the "Reporting Person") is the investment manager to First Round Capital V, LP, a Delaware limited partnership ("FRCV"), and First Round Capital VIII-F, LP, a Delaware limited partnership ("FRCVIIIF"). Josh Kopelman and William Trenchard are the managing members of the Reporting Person. As of October 16, 2023, FRCV held 421,014 ordinary shares, par value NIS 0.35 each ("Ordinary Shares") of Notable Labs, Ltd. and FRCVIIIF held 616,331 Ordinary Shares. The Reporting Person's and Messrs. Kopelman and Trenchard's beneficial ownership is limited to their pecuniary interest, if any, in such securities. /s/ Jeffrey Donnon, Chief Financial Officer of FR Capital Holdings, L.P. 2023-10-26